|
SMAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.309000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.046810E-01 |
| Normal-vs-Stage2 |
5.745600E-01 |
| Normal-vs-Stage3 |
9.632400E-01 |
| Normal-vs-Stage4 |
8.565600E-01 |
| Stage1-vs-Stage2 |
7.936000E-01 |
| Stage1-vs-Stage3 |
1.639410E-01 |
| Stage1-vs-Stage4 |
1.403990E-01 |
| Stage2-vs-Stage3 |
6.110000E-01 |
| Stage2-vs-Stage4 |
5.108200E-01 |
| Stage3-vs-Stage4 |
8.386000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.957600E-01 |
| Normal-vs-AfricanAmerican |
2.940600E-01 |
| Normal-vs-Asian |
7.871600E-01 |
| Caucasian-vs-AfricanAmerican |
3.488200E-02 |
| Caucasian-vs-Asian |
5.590400E-01 |
| AfricanAmerican-vs-Asian |
9.099600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.084200E-01 |
| Normal-vs-Female |
2.238600E-01 |
| Male-vs-Female |
4.858800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.054600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.059450E-01 |
| Normal-vs-Age(61-80Yrs) |
6.433600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.017590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.923000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.547400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.925600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.951040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.552200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.833800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.172560E-01 |
| Normal-vs-Grade 2 |
4.198000E-02 |
| Normal-vs-Grade 3 |
9.797600E-01 |
| Normal-vs-Grade 4 |
7.746400E-01 |
| Grade 1-vs-Grade 2 |
6.772400E-01 |
| Grade 1-vs-Grade 3 |
2.550200E-01 |
| Grade 1-vs-Grade 4 |
2.380600E-01 |
| Grade 2-vs-Grade 3 |
2.879900E-02 |
| Grade 2-vs-Grade 4 |
7.730300E-02 |
| Grade 3-vs-Grade 4 |
7.763000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.357900E-02 |
| Normal-vs-ccB subtype |
2.571200E-01 |
| ccA subtype-vs-ccB subtype |
5.450800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.599600E-01 |
| Normal-vs-N1 |
9.836400E-01 |
| N0-vs-N1 |
5.905200E-01 |
|
|
